UPDATE: Raymond James Initiates Coverage on Accretive Health with Strong Buy Rating, $16 PT
January 16, 2013 at 10:52 AM EST
In a report published Wednesday, Raymond James initiated coverage on Accretive Health (NYSE: AH ) with a Strong Buy rating and $16.00 price target. Raymond James noted, “We initiate coverage of Accretive Health with a Strong Buy rating and $16 price target. Our rating considers what we believe are
